Guardian Capital (Canada)’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,884,769
Closed -$88.8M 178
2022
Q1
$88.8M Buy
3,884,769
+51,439
+1% +$1.26M 1.73% 18
2021
Q4
$106M Sell
3,833,330
-460,116
-11% -$12.3M 2.05% 19
2021
Q3
$120M Sell
4,293,446
-613,961
-13% -$17.4M 2.48% 14
2021
Q2
$144M Buy
4,907,407
+591,054
+14% +$17.9M 2.83% 10
2021
Q1
$172M Sell
4,316,353
-803,921
-16% -$23.6M 2.88% 11
2020
Q4
$106M Buy
5,120,274
+1,469,474
+40% +$27.4M 2.48% 15
2020
Q3
$56.6M Buy
3,650,800
+585,600
+19% +$10.1M 1.49% 23
2020
Q2
$55.9M Buy
+3,065,200
New +$54M 1.45% 25

Other funds holding BHC

Guardian Capital (Canada)'s BHC Position: Q2 2022 in Review

Guardian Capital (Canada) sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 3,884,769 shares — an estimated $88.8M sold.

Guardian Capital (Canada) first reported a position in BHC in Q2 2020 and held it in 8 quarters. The position peaked at $172M in Q1 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Guardian Capital (Canada) reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Guardian Capital (Canada) sold 3,884,769 Bausch Health shares in Q2 2022, an estimated $88.8M.
  • Guardian Capital (Canada) first reported a position in Bausch Health in Q2 2020 and held it in 8 quarters.
  • Guardian Capital (Canada)'s Bausch Health position peaked at $172M in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2022, filed 12 Aug 2022.